From: Opioid treatment program safety measures during the COVID-19 pandemic: a statewide survey
 | Percent (n) | ||
---|---|---|---|
 | Increased Services | Decreased Services | Switched to remote services |
Medications for opioid use disorder (MOUD) (n = 40) | 13 | 5 | 13 |
(5) | (2) | (5) | |
Walk-in/ Same day treatment initiation (n = 21) | 5 | 19 | 5 |
(1) | (4) | (1) | |
Non-MOUD services | |||
 On-site case management and social services (n = 18) | 6 | 17 | 22 |
(1) | (3) | (4) | |
 Referral out to case management and social services (n = 27) | 11 | 26 | 0 |
(3) | (7) | (0) | |
 Individual counseling (n = 42) | 7 | 7 | 55 |
(3) | (3) | (23) | |
 Group counseling (n = 38) | 3 | 18 | 37 |
(1) | (7) | (14) | |
 Drug screening (n = 35) | 9 | 23 | 0 |
(3) | (8) | (0) | |
 Infectious disease services (n = 14) | 7 | 29 | 0 |
(1) | (4) | (0) | |
 Naloxone distribution (n = 25) | 36 | 8 | 4 |
(9) | (2) | (1) |